Organization
Ki Health Partners
2 clinical trials
Clinical trial
A Multi-Center Unblinded Proof-of-Concept Study of DaxibotulinumtoxinA for Migraine Prevention in High-Frequency and Chronic Migraine: the Standard ParadigmStatus: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
A Multi-Center Unblinded Proof-of-Concept Study of DaxibotulinumtoxinA for Migraine: the 'EEG Paradigm'Status: Recruiting, Estimated PCD: 2024-09-01